Verrica Pharmaceuticals (VRCA) Receivables - Net (2023 - 2026)
Verrica Pharmaceuticals (VRCA) posted quarterly Receivables - Net of $7.7 million for Q1 2026, up 37.76% year-over-year from $5.6 million in Q1 2025, and up 46.84% quarter-over-quarter from $5.3 million in Q4 2025.
Verrica Pharmaceuticals (VRCA) Receivables - Net (2023 - 2026) Analysis & Trends
Verrica Pharmaceuticals' Receivables - Net history runs 4 years deep, the most recent figure standing at $7.7 million for Q1 2026.
- In Q1 2026, Receivables - Net rose 37.76% year-over-year to $7.7 million; the TTM figure through Mar 2026 stood at $7.7 million (up 37.76% YoY), while the FY2025 annual figure was $5.3 million, up 10858.33% from the prior year.
- Receivables - Net for Q1 2026 stood at $7.7 million, up from $5.3 million in the prior quarter.
- The five-year high for Receivables - Net was $10.0 million in Q2 2024, with the low at $48000.0 in Q4 2024.
- The 4-year median for Receivables - Net is $6.3 million (2024), against an average of $6.0 million.
- The sharpest annual moves came in 2024 and 2025: Receivables - Net plunged 98.87% in 2024, then soared 10858.33% in 2025.
- Verrica Pharmaceuticals' Receivables - Net stood at $4.2 million in 2023, then slumped by 98.87% to $48000.0 in 2024, then jumped by 10858.33% to $5.3 million in 2025, then soared by 46.84% to $7.7 million in 2026.
- Business Quant data shows VRCA's Receivables - Net at $7.7 million in Q1 2026, $5.3 million in Q4 2025, and $7.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Verrica Pharmaceuticals | 102.80 Mn | 91.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.94 Mn |
| Jun 30, 2026 | 10.94 Mn |
| Mar 31, 2026 | 7.72 Mn |
| Mar 31, 2026 | 7.72 Mn |
| Dec 31, 2025 | 5.26 Mn |
| Dec 31, 2025 | 5.26 Mn |
| Sep 30, 2025 | 7.05 Mn |
| Sep 30, 2025 | 7.05 Mn |
| Jun 30, 2025 | 9.20 Mn |
| Jun 30, 2025 | 9.20 Mn |
| Mar 31, 2025 | 5.61 Mn |
| Mar 31, 2025 | 5.61 Mn |
| Dec 31, 2024 | 48,000.00 |
| Dec 31, 2024 | 48,000.00 |
| Jun 30, 2024 | 10.00 Mn |
| Jun 30, 2024 | 10.00 Mn |
| Mar 31, 2024 | 7.00 Mn |
| Mar 31, 2024 | 7.00 Mn |
| Dec 31, 2023 | 4.25 Mn |
| Dec 31, 2023 | 4.25 Mn |